direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Page Content

German Health Care System

2018

  • Ex P, Felgner S, Henschke C (2018): Rechtsprechungen zur Kostenerstattung von neuen Gesundheitstechnologien in der GKV: Eine systematische Übersicht. [1]
  • Blümel M, Busse R (2018): The “Bismarck-Model”: Germany’s health insurance system in its historical context. [2]

2017

  • Stephani V, Geissler A, Busse R (2017): Kooperation und Integration von Krankenhäusern - Potentiale für disruptive Innovationen? [3]
  • Weiss B, Marschall U, Busse R, Mansmann U, Caumanns J, Rosseau S, Seeling M, Spies C (2017): ERIC – Enhanced Recovery after Intensive Care. [4]
  • Scheller-Kreinsen D, Lehmann K, Quentin W, Kaiser P Haun O (2017): Ambulant-stationäre Grenze: endlich aufräumen [5]
  • Stephani V, Sommariva S, Spranger A, Ciani O (2017): Non-communicable diseases: mapping research funding organisations, funding mechanisms and research practices in Italy and Germany. [6]

2016

  • Blümel M, Busse R (2016): The German Health Care System 2015 [7]
  • Ex P, Busse R, Henschke C (2016): Die Nutzenbewertung von nichtmedikamentösen Untersuchungs- und Behandlungsmethoden [8]
  • Siegel M, Koller D, Vogt V, Sundmacher L (2016): Developing a composite index of spatial accessibility across different health care sectors: A German example [9]
  • Vogt V (2016): The contribution of locational factors to regional variations in office-based physicians in Germany [10]

2015

  • Busse R, Panteli D, Henschke C (2015): Arzneimittelversorgung in der GKV und 15 anderen europäischen Gesundheitssystemen. Universitätsverlag der TU Berlin [11]
  • Blümel M, Busse R (2015): The German Health Care System, 2014. In: Mossialos E, Wenzl M, Osborn R, Anderson C (eds.) International Profiles of Health Care Systems, 2014, The Commonwealth Fund, January 2015 [12]
  • Röttger J et al (2015): Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methology [13]

2014

  • Baier N, Struckmann V (2014): Review zu den Perspektiven der ländlichen Versorgung. Ein Überblick international bestehender Ansätze. Working Papers in Health Policy and Management Vol. 9, 2014, Universitätsverlag der Technischen Universität Berlin [14]
  • Blümel M, Panteli D, van Ginneken E (2014): Assuring quality of inpatient care in Germany: existing and new approaches. EuroHealth 20 (3): 52-55 [15]
  • Busse R, Blümel M (2014): Germany: Health system review. Health Systems in Transition. 16(2): 1-296 [16]
  • Fuchs S, Henschke C, Blümel M, Busse R (2014): Disease-Management-Programme für Diabetes mellitus Typ 2 in Deutschland – Abschätzung der Effektivität anhand einer systematischen Literaturübersicht. Dt Ärzteblatt Int 111(26): 453-463 [17]
  • Garms-Homolová V, Busse R (2014): Monitoring the quality of long-term care in Germany. In: Mor V, Leone T, Maresso A (eds.) Regulating Long-term Care Quality: An International Comparison. Cambridge: Cambridge Univer­sity Press, p. 67-101 [18]
  • Siegel M, Vogt V, Sundmacher L (2014): From a conservative to a liberal welfare state: Decomposing changes in income-related health inequalities in Germany, 1994–2011. Soc Sci Med 108: 10-19 (DOI: 10.1016/j.socscimed.2014.02.022) [19]

2013

  • Busse R, Blümel M, Ognyanova D (2013): Das deutsche Gesundheitssystem. MWV Medizinisch Wissenschaftliche Verlagsgesellschaft mbH & Co.KG [20]
  • Busse R , Schreyögg J, Stargardt T (Hrsg.) (2013): Management im Gesundheitswesen. Das Lehrbuch für Studium und Praxis. 3., vollständig überarbeitete und erweiterte Auflage. Berlin-Heidelberg: Springer [21]
  • Busse R, Siegel M, Sundmacher L und die Mitglieder des Gesundheitsökönomischen Zentrums Berlin (2013): Gesundheitsökonomisches Zentrum Berlin (Berlin HECOR). Public Health Forum 21(4): 22.e1-22.e3 [22]

2012

  • Kreis J, Busse R (2012): From evidence assessments to coverage decisions? The case example of glinides in Germany. Health Policy 104(1): 27-31 [23]

2011

  • Busse R, Blümel M, Stock S (2011): The German Health Care System, 2011. In: THOMSON S, OSBORN R, SQUIRES D, REED SJ (eds.) [24]
  • Ognyanova D, Zentner A, Busse R (2011): Pharmaceutical reform 2010 in Germany: striking a balance between innovation and affordability. Eurohealth 17(1): 11-13 [25]
  • Scheller-Kreinsen D, Quentin W, Geissler A, Busse R (2011): DRG-type hospital payment systems in Europe: the German G-DRG system and the English Health Care Resources Groups (HRGs). In: Klusen N, ... [26]

2006

  • Grabka M, Schreyögg J, Busse R(2006):The impact of co-payments on patient behavior: evidence from a natural experiment [27]
  • Schreyögg J, Tiemann O, Busse R (2006): Cost accounting to determine prices: how well do prices reflect costs in the German DRG-system? Health Care Management Science 9(3): 269-279 [28]
  • Weinbrenner S, Busse R (2006): Germany. In: Rechel B , Dubois C-A, McKee M (eds.) The Health Care Workforce in Europe – Learning from experience. Copenhagen/ Brussels: European Observatory on Health Systems and Policies, S. 33-46 [29]

2005

  • Busse R, Schreyögg J, Henke K-D (2005): Pharmaceutical Regulation in Germany: improving efficiency and controlling expenditures. International Journal of Health Planning and Management 20(4): 329-349 [30]
  • Busse R, Stargardt T, Schreyögg J (2005): Determining the benefit basket of the Statutory Health Insurance scheme in Germany: methodologies and criteria. European Journal of Health Economics 6(Suppl 1): 30-36 [31]
  • Schreyögg J, Busse R (2005): Disease management in Germany. EuroObserver 7(2): 3-4 [32]
  • Schreyögg J, Busse R (2005): Physician drug budgets in Germany: effects on prescription behaviour. Journal of Pharmaceutical Finance, Economics & Policy 14(3): 77-95 [33]
  • Wörz M, Busse R (2005): Analysing the impact of health care system change in the EU member states - Germany. Health Economics 14(S1): S133-S149 [34]

2004

  • Busse R (2004): Disease Management Programs in Germany’s Statutory Health Insurance System - A Gordian Solution to the Adverse Selection of Chronically Ill in Competitive Markets? Health Affairs 23(3): 56-67 [35]
  • Busse R, Nolte E (2004): New citizens: East Germans in a united Germany. In: Healy J, McKee M (eds.) Accessing Healthcare - Responding to diversity. Oxford: Oxford University Press: 127-144 [36]
  • Busse R, Riesberg A (2004): Health care systems in transition: Germany. Copenhagen: WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies [37]
  • Busse R, Wörz M (2004): The ambiguous experience with privatisation in German health care. In: Maarse H (ed.) Privatisation in European health care - A comparative analysis in eight countries. Maarsen: Elsevier Gezondheidszorg, S. 79-95 [38]
  • Henke K-D, Borchardt K, Schreyögg J, Farhauer O (2004): Eine Systematisierung der Reformvorschläge zur Finanzierung der Krankenversorgung in Deutschland; Evaluating reform proposals for financing health care in Germany. Journal of Public Health 12(1):10 [39]
  • Velasco Garrido M, Busse R (2004): Alemania: Calidad y Financiación de la Asistencia en Crisis. Ars Médica Revista de Humanidades 3(1): 57-73 [40]

2003

  • Busse R, Wörz M (2003): Germany plans for “health care modernisation”. Eurohealth 9(1): 21-24 [41]
  • Dixon A, Riesberg A, Weinbrenner S, Saka O, Le Grand J, Busse R (2003). Complementary and alternative medicine in the UK and Germany: A synthesis of research and evidence on supply and demand. London, Berlin: Anglo-German Foundation [42]
  • Riesberg A, Busse R (2003): Cost-shifting (and modernization) in German health care. EuroObserver 5(4): 4-5 [43]

2002

  • Busse R (2002): Germany. In: European Observatory on Health Care Systems (ed.) Health care systems in eight countries – trends and challenges. London: London School of Economics, p. 47-60 [44]
  • Busse R (2002): Health care systems: Germany and Britain compared/ Health care delivery - towards an agenda for policy learning between Britain and Germany. London: Anglo-German Foundation for the Study of Industrial Society [45]
  • Thomson SMS, Busse R, Mossialos E (2002): Low demand for substitutive voluntary health insurance in Germany. Croatian Medical Journal 43(4): 425-432 [46]
  • Wörz M, Busse R (2002): Structural reforms for Germany’s health care system? EuroObserver 4(4): 1-3 [47]

2001

  • Busse R (2001): Risk structure compensation in Germany´s statutory health insurance. Eur J Public Health 11(2): 74-77 [48]
  • Perleth M, Busse R, Gibis B, Brand A (2001): Evaluation of preventive technologies in Germany – Case studies on mammography, prostate cancer screening and fetal ultrasound. Int J Technology Assessment Health Care 17(3): 329-337 [49]
  • Wörz M, Wismar M (2001): Green politics in Germany: what is Green health care policy? Int J Health Serv 31(4): 847-867 [50]

2000

  • Busse R (2000): Health care systems in transition – Germany. Written in collaboration with A. Riesberg and edited by A. Dixon; also in German and Russian. Copenhagen: European Observatory on Health Care Systems [51]
  • Busse R (2000): Germany. In: Wieners WW (ed.) Global health care markets: A comprehensive guide to regions, trends, and oppor­tu­ni­ties shaping the inter­national health arena. San Francisco: Jossey Bass, p. 139 [52]
  • Perleth M, Busse R (2000): Health technology assessment in Germany: Status, challenges, and development. Int J Technology Assessment Health Care 16(2): 412-428 [53]

1999

  • Busse R (1999): Priority-setting and rationing in German health care. Health Policy 50(1/2): 71-90 [54]
  • Busse R, Howorth C (1999): Cost containment in Germany: twenty years experience. In: Mossialos E, LeGrand J (eds.) Health care and cost containment in the European Union. Aldershot: Ashgate, p. 303-339 [55]
  • Busse R, Schwartz FW (1999): Decision-Making and Priority-Setting in Public Health and Health Care in Germany. In: Holland W, Mossialos E, Belcher P, Merkel B (eds.) Public Health Policies in the European Union. Aldershot: Ashgate, p. 105-126 [56]
  • Perleth M, Busse R, Schwartz FW (1999): Regulation of health-related technologies in Germany. Health Policy 46(2): 105-126 [57]

1997

  • Busse R, Schwartz FW (1997): Financing reforms in the German hospital sector - From full cost cover principle to prospective case fees. Med Care 35(10): OS40-OS49 [58]
  • Busse R, Schwartz FW (1997): The Philippines' National Health Insurance Act - a German Perspective. Int J Health Planning and Management 12(2): 131-148 [59]

To top

------ Links: ------

Zusatzinformationen / Extras

Quick Access:

Schnellnavigation zur Seite über Nummerneingabe

Copyright TU Berlin 2008